July 23, 2007
Yoshikazu Yoshida, deputy director of the Strategic Marketing Unit of Chugai Pharmaceutical's Oncology Area Disease Department, told Jiho, Inc. that the number of patients registered for a special clinical experience investigation (all-patient post-marketing surveillance (PMS)) on his company's anticancer agent...read more